HC Wainwright Brokers Reduce Earnings Estimates for EBS
Emergent BioSolutions Inc. (NYSE:EBS – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings estimates for Emergent BioSolutions in a research note issued to investors on Thursday, May 15th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will post earnings of ($0.26) per share for the quarter, […]
Emergent BioSolutions Inc. (NYSE:EBS – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings estimates for Emergent BioSolutions in a research note issued to investors on Thursday, May 15th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will post earnings of ($0.26) per share for the quarter, […]
